POTENZA THERAPEUTICS
Potenza Therapeutics, Inc. is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs that utilize the body’s own immune system to seek out, recognize and destroy tumors through a diversity of mechanisms that influence tumor immunity. It was founded in 2014 and headquartered in Cambridge, Massachusetts.
POTENZA THERAPEUTICS
Industry:
Biopharma Biotechnology Oncology Therapeutics
Founded:
2014-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.potenzatherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
(617)588-4150
Email Addresses:
[email protected]
Total Funding:
35 M USD
Technology used in webpage:
SPF Amazon Amazon Virginia Region NameBright
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Employees Featured
Founder
Investors List
InterWest Partners
InterWest Partners investment in Venture Round - Potenza Therapeutics
MPM Capital
MPM Capital investment in Venture Round - Potenza Therapeutics
Official Site Inspections
http://www.potenzatherapeutics.com
- Host name: ec2-13-223-25-84.compute-1.amazonaws.com
- IP address: 13.223.25.84
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Potenza Therapeutics"
Potenza Therapeutics - Crunchbase Company Profile & Funding
Potenza Therapeutics, Inc. is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs that utilize the body’s own immune system to seek out, …See details»
Potenza Therapeutics 2025 Company Profile: Valuation, …
Potenza Therapeutics General Information Description. Operator of a biotechnology company intended build a portfolio of oncology programs that …See details»
Potenza Therapeutics - Overview, News & Similar companies
Who is Potenza Therapeutics. Potenza Therapeutics is a biotechnology company focused on building a diverse portfolio of oncology programs that utilize the body's own immune sys tem …See details»
Astellas Acquires Potenza Therapeutics - Dec 14, 2018
Dec 14, 2018 TOKYO and NORTHBROOK, Ill., Dec. 14, 2018 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that it exercised, and closed on its exclusive …See details»
Potenza Therapeutics Inc - Company Profile and News
Company profile page for Potenza Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
POTENZA Therapeutics Overview | SignalHire Company Profile
POTENZA Therapeutics is a private company that has been in the industry for 10 years. The company currently specializes in the Biotechnology, Biotechnology areas. ... Organization …See details»
Potenza Therapeutics - Craft
Potenza Therapeutics Summary. Company Summary. Overview. Potenza Therapeutics is a biotechnology company focused on building a diverse portfolio of oncology programs that …See details»
Potenza Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...
Jun 18, 2023 Explore Potenza Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 literature, Disease Domain:Neoplasms, Technology Platform ...See details»
Potenza Therapeutics - Owler
Potenza Therapeutics’s Profile, Revenue and Employees. Potenza Therapeutics is a biotechnology company that develops immuno-oncology therapies. Potenza Therapeutics’s …See details»
Potenza Therapeutics, Inc.:Company Profile & Technical Research ...
Potenza Therapeutics, Inc. is a company that provides Biotechnology, Oncology, Pharmacy and Therapeutics and more. Potenza Therapeutics, Inc. is headquartered in United States …See details»
Potenza Therapeutics - Products, Competitors, Financials, …
Webinar Digitize remote site monitoring with Box Box will discuss how your life sciences organization can continue to propel therapies & devices through the value chain with faster …See details»
Organization | Potenza Therapeutics
Organization Overview. First Clinical Trial. 2017 NCT03260322. First Marketed Drug. None First NDA Approval. None Last Known Activity ... Potenza Therapeutics Active Ingredients. Drugs in …See details»
Potenza Therapeutics CEO and Key Executive Team | Craft.co
Potenza Therapeutics's President and Chief Executive Officer is Dan J. Hicklin. Other executives include David Cordo, CFO; Reid J. Leonard, COO and 3 others. See the full leadership team …See details»
Potenza Therapeutics - Tech Company Profile - Gaebler.com …
Potenza Therapeutics is focusing on the discovery and development of novel immune-oncology therapeutics: Molecules that stimulate the power of the immune system to fight cancer. Profile. …See details»
Astellas Pharma and Potenza Therapeutics Partner to Build a …
The organization is committed to becoming a global category leader in Urology, Immunology (including Transplantation) and In fectious diseases, Onco logy, Neuroscience and Diabetes …See details»
Potenza Therapeutics Unveils Pipeline of Immuno-Oncology …
Jan 5, 2018 Potenza Therapeutics provides insights into its portfolio of immuno-oncology therapies. Contacts MacDougall Biomedical Communications Amanda Houlihan, 781-235 …See details»
Astellas Acquires Potenza Therapeutics - PR Newswire
Dec 14, 2018 TOKYO and NORTHBROOK, Ill., Dec. 14, 2018 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that …See details»
Astellas buys Potenza Therapeutics for up to $405m
Dec 17, 2018 Potenza Therapeutics president and CEO Dan Hicklin said: “Over the past three and a half years, we have enjoyed a successful and productive partnership with Astellas. “I am …See details»
Astellas gains three cancer drugs with $405m Potenza buy
Dec 14, 2018 Astellas has taken an option to acquire US biotech Potenza Therapeutics after the companies spent more than three years working together on cancer immunotherapies. The …See details»
Astellas and Potenza partner to develop immune-oncology …
Apr 23, 2015 Japan-based Astellas Pharma has entered an exclusive research and development collaboration agreement with Potenza Therapeutics to develop a portfolio of …See details»